Our world class science and unwavering commitment to innovation spans
over two decades; three immunology therapy areas, 14 immune mediated
diseases and 100 clinical trials.
Our scientists have set the standard in treatment for immunology
and we continue to invest in ground breaking science and technology
striving for the next-generation of treatments.
Utilising our experience in disease areas beyond immunology, we’ve
helped to progress personalised medicine from a hypothetical concept
to a reality in oncology, where today we are researching the ability
to target and inhibit multiple pathways at once.